• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Rapidly improving neurological deficit of stroke; case series in Academic institute, KAUH, Jeddah (P4.283)
Conclusions:Rapidly improving patient represent a challenge to whether tPA should be given. However, the good outcome with thrombolytic therapy observed in our study, will hopfuly support the decision to treat.Study Supported by: nonDisclosure: Dr. khoja has nothing to disclose. Dr. Alshaer has nothing to disclose. Dr. al-Turkistani has nothing to disclose. Dr. Al-Mekhalfi has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: khoja, a., Al-Shaer, D., al-Turkistani, a., Al-Mekhalfi, M. Tags: Thrombolysis and Acute Evaluation in Ischemic Stroke Source Type: research

Contrast induced encephalopathy mimicking reperfusion injury (P3.285)
Conclusions:Diagnostic or therapeutic angiography is frequently performed for acute ischemic or hemorrhagic stroke. Clinicians should be aware of contrast induced encephalopathy and consider it in cases of neurologic deterioration after angiography in order to initiate appropriate treatment and avoid unnecessary invasive tests.Disclosure: Dr. Bakradze has nothing to disclose. Dr. Pasquale has nothing to disclose. Dr. Kirchoff-Torres has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Bakradze, E., Pasquale, D., Kirchoff-Torres, K. Tags: Cerebrovascular Disease Case Reports II Source Type: research

Vascular Territories of Ischemic Stroke in Associated Takotsubo Cardiomyopathy (P1.221)
Conclusions: TC is a reversible cardiomyopathy that has an association with ischemic stroke. This condition can notably be both the cause and effect of stroke. Ischemic stroke of the left middle cerebral artery appears to be the most prevalent. In female patients suffering from middle cerebral artery distribution ischemic stroke and cardiac dysfunction, TC should be considered.Disclosure: Dr. Zia has nothing to disclose. Dr. Silliman has received research support from Genzyme Corporation, Biogen Idec, and Novartis.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Zia, A., Silliman, S. Tags: Cardiac Mechanisms and Complications of Stroke Source Type: research

Pediatric cavernous sinus thrombosis: A case series and review of the literature
Conclusion: Our case series demonstrates low morbidity and mortality with early, aggressive surgical, antimicrobial, and anticoagulation therapies. Although anticoagulation and surgery were not associated with significantly different outcomes, more study is needed.
Source: Neurology - August 31, 2015 Category: Neurology Authors: Smith, D. M., Vossough, A., Vorona, G. A., Beslow, L. A., Ichord, R. N., Licht, D. J. Tags: Childhood stroke, Secondary headache disorders, Pediatric headache, All Imaging, Cerebral venous thrombosis ARTICLE Source Type: research

Functional Outcome After Perinatal Cerebral Sinovenous Thrombosis: A Prospective Cohort Study (S42.006)
CONCLUSIONS: We found a high rate of neurological morbidity and seizure burden after perinatal CSVT which significantly impacted achievement of age-appropriate developmental milestones and function. Measures and predictors of functional outcome following perinatal CSVT need further exploration.Disclosure: Dr. Billinghurst has nothing to disclose. Dr. Uohara has nothing to disclose. Dr. Licht has nothing to disclose. Dr. Ichord has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Billinghurst, L., Uohara, M., Licht, D., Ichord, R. Tags: Child Neurology I Source Type: research

Compliance with Early Use of Prophylactic Anticoagulation after Intracerebral Hemorrhage (P02.047)
CONCLUSIONS: Despite implementation of guideline-based practice, 12% of our ICH patients did not receive early prophylactic anticoagulation despite a clear lack of contraindication. Continued quality improvement towards guideline-driven care may be enhanced by the use of checklists to overcome individual physician biases and preferences.Disclosure: Dr. Hoang has nothing to disclose. Dr. John has nothing to disclose. Dr. Garg has received research support from the AHA. Dr. Busl has nothing to disclose. Dr. Temes has nothing to disclose. Dr. Bleck has nothing to disclose. Dr. Prabhakaran has nothing to disclose.
Source: Neurology - February 14, 2013 Category: Neurology Authors: Hoang, T., John, S., Garg, R., Busl, K., Temes, R., Bleck, T., Prabhakaran, S. Tags: P02 Cerebrovascular Disease II Source Type: research